| SMIHigh (n = 41) | SMILow (n = 42) | P value |
---|
CRP | 0.789 ± 0.928 | 1.273 ± 2.731 | 0.245 |
Albumin | 3.7 ± 0.5 | 3.5 ± 0.7 | 0.296 |
PNI | 45.05 ± 5.73 | 42.4 ± 8.7 | 0.108 |
NLR | 2.567 ± 1.081 | 4.110 ± 4.560 | 0.047 |
CAR | 0.220 ± 0.255 | 0.514 ± 1.264 | 0.308 |
PLR | 189.0 ± 103.7 | 224.9 ± 135.2 | 0.226 |
CEA | 18.3 ± 49.1 | 16.7 ± 38.4 | 0.604 |
CA19–9 | 334.9 ± 1198.2 | 111.6 ± 416.2 | 0.610 |
- Data are presented as the mean ± standard deviation or number (percentage) of patients
- CA19–9, carbohydrate antigen; CEA, carcinoembryonic antigen; CRP, C-reactive protein; CAR, C-reactive protein-to-albumin ratio; NLR, neutrophil to lymphocyte ratio; PLR, platelet to lymphocyte ratio; PNI, the prognostic nutritional index; SMIHigh, high skeletal muscle mass; SMILow, low skeletal muscle mass; UGC, unresectable gastric cancer